Journal
Drug Safety
Publication Date
2018
Volume
41
Issue
8
Inclusive Pages
807-816
Document Type
Open Access Publication
DOI
10.1007/s40264-018-0669-8
Rights and Permissions
Parikh, A., Stephens, K., Major, E. et al. Drug Saf (2018) 41: 807. https://doi.org/10.1007/s40264-018-0669-8 This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Recommended Citation
Parikh, Asit; Stephens, Kristin; Major, Eugene; Fox, Irving; Milch, Catherine; Sankoh, Serap; Lev, Michael H.; Provenzale, James M.; Shick, Jesse; Patti, Mark; McAuliffe, Megan; Berger, Joseph R.; and Clifford, David B., "A programme for risk assessment and minimisation of progressive multifocal leukoencephalopathy developed for vedolizumab clinical trials." Drug Safety. 41, 8. 807-816. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7489
Supplemental Material
